Medicaid’s Home Care Support for Family Caregivers in 2026
This issue brief provides new information about family caregivers from KFF’s most recent survey of…
This issue brief provides new information about family caregivers from KFF’s most recent survey of state Medicaid HCBS programs, including a discussion of what home care supports for family caregivers states offer, including paid caregiving, respite care, and self-directed services.
This analysis examines out-of-pocket costs on insulin among Medicare Part D enrollees between 2020 and 2024 to assess changes over time as voluntary and mandatory insulin copay limits took effect. The implementation of these measures resulted in a substantial reduction in out-of-pocket spending by enrollees without low-income subsidies who used insulin, with out-of-pocket spending on…
This Issue Brief explains the evolution of cost-sharing caps for insulin in recent years, including existing state laws, the proposed federal legislation, and key policy considerations when assessing whether this approach may improve insulin affordability for consumers.
A week before the midterm elections, a dozen Democratic senators sent harshly critical letters to 10 health insurance company CEOs. Why, the letters asked, had those insurers cooperated with what they called a “potentially unlawful” Trump administration effort that resulted in the rapid cancellation of coverage for 760,000 Affordable Care Act enrollees in late August?…
With all the jargon, the price tags, and having to guess your income and health needs for the year ahead, it’s no wonder first-time shoppers can feel lost when choosing a health plan. But there’s free help out there if you know where to look. HealthQ host Blake Farmer joined WAMU’s Health Hub on Nov….
By LORENZO GIUNTINI For years, I was the person leaving a medical appointment with another scan, another report, and too many unanswered questions. Chronic pain has a way of making every unfamiliar word feel urgent. I did not need a machine to replace a radiologist. I wanted someone to explain what the existing medical record…
On a panel at HLTH, experts discussed prior authorization denials and who should make the final call. The post Who Should Make Medical-Necessity Decisions: AI, Insurers or Treating Physicians? appeared first on MedCity News.
On a panel on employee benefits Ali Diab, CEO of Collective Health, spoke plainly about the market forces that hamper self-insured employers from designing the best employee benefits. The post Independent Benefits Platform Leader: Market Forces Prevent Employers From Getting Best Solution appeared first on MedCity News.
Sanofi’s Infilbray is now approved for treating Gaucher disease type 3. The brain-penetrating small molecule is the first FDA-approved therapy for the neurological symptoms of this rare enzyme deficiency. The post FDA Approval for Sanofi Drug Marks an Important First in Rare Disease appeared first on MedCity News.
Impact Advisors’ Ash Shehata explains how health systems can plan ERP transitions, manage costs and complexity, and avoid common implementation pitfalls